Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.
AUTOR(ES)
Kinkel, R P
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=486706Documentos Relacionados
- Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.
- Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
- Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
- Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.
- Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.